Stephens Consulting’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,500
Closed -$2.27K 487
2023
Q4
$2.27K Hold
1,500
﹤0.01% 427
2023
Q3
$2.4K Hold
1,500
﹤0.01% 427
2023
Q2
$3.25K Hold
1,500
﹤0.01% 413
2023
Q1
$2.19K Hold
1,500
﹤0.01% 453
2022
Q4
$1.88K Hold
1,500
﹤0.01% 433
2022
Q3
$2.83K Hold
1,500
﹤0.01% 464
2022
Q2
$3.79K Hold
1,500
﹤0.01% 425
2022
Q1
$5.16K Sell
1,500
-1,500
-50% -$5.3K ﹤0.01% 430
2021
Q4
$14.4K Buy
+3,000
New +$12.1K 0.01% 349

Other funds holding OPK

Stephens Consulting's OPK Position: Q1 2024 in Review

Stephens Consulting sold out of Opko Health (OPK) in Q1 2024, closing a stake of 1,500 shares — an estimated $2.27K sold.

Stephens Consulting first reported a position in OPK in Q4 2021 and held it in 9 quarters. The position peaked at $14.4K in Q4 2021. 226 funds tracked by Wall St. Rank hold OPK as of Q1 2024.

  • Stephens Consulting reported no remaining Opko Health position as of Q1 2024 after selling out during the quarter.
  • Stephens Consulting sold 1,500 Opko Health shares in Q1 2024, an estimated $2.27K.
  • Stephens Consulting first reported a position in Opko Health in Q4 2021 and held it in 9 quarters.
  • Stephens Consulting's Opko Health position peaked at $14.4K in Q4 2021.
  • 226 funds tracked by Wall St. Rank held Opko Health as of Q1 2024.

Based on Stephens Consulting's 13F filing for Q1 2024, filed 17 Apr 2024.